Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prominin 2 decreases cisplatin sensitivity in non-small cell lung cancer and is modulated by CTCC binding factor. | Radiol Oncol | 2023 | 37665741 | PubTator, text mining | PubMed |
| A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities. | Dis Model Mech | 2023 | 37661832 | PubTator, text mining | PubMed |
| Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis. | Nat Commun | 2023 | 37658085 | PubTator, text mining | PubMed |
| Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges. | Cell Regen | 2023 | 37656237 | PubTator, text mining | PubMed |
| Photo-click hydrogels for 3D in situ differentiation of pancreatic progenitors from induced pluripotent stem cells. | Stem Cell Res Ther | 2023 | 37649117 | PubTator, text mining | PubMed |
| Current Status and Future Trends of Cold Atmospheric Plasma as an Oncotherapy. | Biomol Ther (Seoul) | 2023 | 37641880 | PubTator, text mining | PubMed |
| Four types of adenine-related RNA modification writers -mediated molecular subtypes contribute to predicting clinical outcomes and treatment options in bladder cancer. | Front Immunol | 2023 | 37638051 | PubTator, text mining | PubMed |
| Expression of HOXA10 Gene in Women with Endometriosis: A Systematic Review. | Int J Mol Sci | 2023 | 37629050 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Features of Uveal Melanoma-An Overview and Clinical Implications. | Int J Mol Sci | 2023 | 37628989 | PubTator, text mining | PubMed |
| Homeobox Gene Expression Dysregulation as Potential Diagnostic and Prognostic Biomarkers in Bladder Cancer. | Diagnostics (Basel) | 2023 | 37627900 | PubTator, text mining | PubMed |
| Construction and validation of a cuproptosis-related diagnostic gene signature for atrial fibrillation based on ensemble learning. | Hereditas | 2023 | 37620966 | PubTator, text mining | PubMed |
| Methylation across the central dogma in health and diseases: new therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37620312 | PubTator, text mining | PubMed |
| Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia. | J Cancer Res Clin Oncol | 2023 | 37606761 | PubTator, text mining | PubMed |
| An "unexpected" role for EMT transcription factors in hematological development and malignancy. | Front Immunol | 2023 | 37600794 | PubTator, text mining | PubMed |
| Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia. | Leukemia | 2023 | 37587260 | PubTator, text mining | PubMed |
| Global endometrial DNA methylation analysis reveals insights into mQTL regulation and associated endometriosis disease risk and endometrial function. | Commun Biol | 2023 | 37587191 | PubTator, text mining | PubMed |
| Mixed-Lineage Leukemia 1 Inhibition Enhances the Differentiation Potential of Bovine Embryonic Stem Cells by Increasing H3K4 Mono-Methylation at Active Promoters. | Int J Mol Sci | 2023 | 37569280 | PubTator, text mining | PubMed |
| YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells. | Cancers (Basel) | 2023 | 37568827 | PubTator, text mining | PubMed |
| Spotlight on the Expanding Role of miR-647 in Human Cancers. | Adv Biomed Res | 2023 | 37564440 | PubTator, text mining | PubMed |
| Identification of potential DNA methylation biomarkers related to diagnosis in patients with bladder cancer through integrated bioinformatic analysis. | BMC Urol | 2023 | 37563710 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=16